
My Chromosomes
Next talks:
BrazMedChem 2014 Sao Carlos, Brazil, 9-13 November 2014
SLAS (Society for Laboratory Automation & Screening) 2014 San Diego, California/US, 18-22 January 2014
iPoPS 2013 Shah Alam, Malaysia, 4/5 September 2013
eSSENCE International Workshop on Macromolecular Structure and Dynamics Uppsala, Sweden, 3-5 June 2013
Informa Drug Discovery Innovations Berlin, Germany, 19/20 March 2013
Advances and Progress in Drug Design London, UK, 18-19 February 2013
UiTM Academic Conference 2013 Kuala Lumpur, Malaysia, 29-30 January 2013
German Cheminformatics Conference 2012 Goslar, Germany, 11-13 November 2012
MipTec 2012 Basle, Switzerland, 24-27 September 2012
Symposium on Computational Chemical Biology Manchester, UK, 13 September 2012
22nd International Symposium on Medicinal Chemistry (EFMC-ISMC 2012) Berlin, Germany, 2-6 September 2012
2012 Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM) Shanghai, China, 27-29 June 2012
SocBIN Bioinformatics 2012 Stockholm, Sweden, 11-14 June 2012
Good Practice in Traditional Chinese Medicine (GP-TCM) Leiden, The Netherlands, 15-18 April 2012
RIKEN Chemical Biology Symposium Wako, Japan, 20-21 October 2011
47th International Conference on Medicinal Chemistry (Plenary Lecture) Lyon, France, 6-8 July 2011
Frontiers in Medicinal Chemistry 2011 Saarbruecken, Germany, 20-23 March 2011
Global Discovery & Development Innovation Forum 2011
London, U. K., 7-8 March 2011
World Drug Discovery & Development Summit 2010 Copenhagen, Denmark, 26-27 October 2010
XIXth LACDR School on Medicinal Chemistry Oegstgeest, The Netherlands, 19-22 October 2010
UK QSAR Meeting Fall 2010 Cambridge, UK, 12 October 2010
FIGON Dutch Medicines Days 2010 Lunteren, The Netherlands, 4-6 October 2010
21st International Symposium on Medicinal Chemistry Brussels, Belgium, 5-9 September 2010
Second Strasbourg Summer School on Chemoinformatics Obernai, France, 20-24 June 2010
Bio-IT World 2010 Boston/MA, 20-22 April 2010
British Toxicology Society Annual Meeting 2010 Edinburgh, 28-31 March 2010
In silico discovery of molecular probes and drug-like compounds: Success & Challenges Ile de France, France, 23-25 March 2010
Fragment-Based Lead Design 2009 York/UK, 20-23 September 2009
DrugInfoMeet Cochin/India, 19-21 August 2009
Bio-IT World Conference & Expo Boston/USA, 27-29 April 2009
Addis Ababa University Addis Ababa/Ethiopia, 9 January 2009
MIPTEC '08 Basel/Switzerland, 14-16 October 2008
Virtual Discovery Europe Amsterdam/The Netherlands, 19-20 June 2008
8th International Conference on Chemical Structures Noordwijkerhout/The Netherlands, 1-5 June 2008
Bio-IT World Conference & Expo Boston/USA, 28-30 April 2008
6th Annual Congress: G Protein-Coupled Receptors in Drug Discovery Berlin/Germany, 10-13 March 2008
|
Recent publications (More Publications)
98. Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data.
Gerard J. P. van Westen, et al., PLoS Comp. Biol. 2013 (9) e1002899.

read article
|
97. Chemogenomics Approaches to Rationalizing the Mode-of-Action of Traditional Chinese and Ayurvedic Medicines.
Fazlin Mohd Fauzi, et al., J. Chem. Inf. Model. 2013 (53) 661 - 673.

read article
|
96. Experimental Validation of In Silico Target Predictions on Synergistic Protein Targets.
Isidro Cortes-Ciriano, et al., MedChemComm 2013 (4) 278 - 288.

read article
|
95. Identifying Novel Adenosine Receptor Ligands by Simultaneous Proteochemometric Modeling of Rat and Human Bioactivity Data.
Gerard J. P. van Westen, et al., J. Med Chem. 2012 (55) 7010 - 7020.

read article
|
94. A Two-Directional Strategy for the Diversity-Oriented Synthesis of Macrocyclic Scaffolds.
Kieron O'Connell, et al., Org. Biomol. Chem. 2012 (10) 7545 - 7551.

read article
|
93. Using multiobjective optimization and energy minimization to design an isoform-selective ligand of the 14-3-3 protein.
Hernando Sanchez-Faddeev, et al., Lect. Notes. Comput. Sci. 2012 (7610) 12 - 24.

read article
|
92. Multi-Objective Evolutionary Design of Adenosine Receptor Ligands.
Eelke van der Horst, et al., J. Chem. Inf. Model. 2012 (52) 1713 - 1721.

read article
|
91. Predicting Genes Involved in Human Cancer Using Network Contextual Information.
Hossein Rahmani, et al., J. Integr. Bioinf. 2012 (9) 210.

read article
|
90. A Prospective Cross-Screening Study on G Protein-Coupled Receptors: Lessons Learned in Virtual Compound Library Design.
Marijn P. A. Sanders, et al., J. Med Chem. 2012 (55) 5311 - 5325.

read article
|
89. Cheminformatics.
Joerg K. Wegner, et al., Comm. ACM 2012 (55) 65 - 75.

read article
|
88. Recognizing Pitfalls in Virtual Screening: A Critical Review.
Thomas Scior, et al., J. Chem. Inf. Model. 2012 (52) 867 - 881.

read article
|
87. A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles.
Thomas M. Beale, et al., ACS Med. Chem. Lett 2012 (3) 177 - 181.

read article
|
86. Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms.
Johannes Kirchmair, et al., J. Chem. Inf. Model. 2012 (52) 617 - 648.

read article
|
85. The challenges involved in Modeling Toxicity Data in silico: A Review.
M. Paul Gleeson, et al., Curr. Pharm. Des. 2012 (18) 1266 - 1291.

read article
|
84. Bridging Chemical and Biological Data: Implications for Pharmaceutical Drug Discovery.
Jeremy L. Jenkins et al., in Computational Approaches in Cheminformatics and Bioinformatics. Rajarshi Guha and Andreas Bender (Eds.), Wiley, New York 2011.

read article
|
83. Understanding and Classifying Metabolite Space and Metabolite-Likeness.
Julio E. Peironcely, Theo Reijmers, Leon Coulier, Andreas Bender and Thomas Hankemeier, PLoS One 2011 e28966.

read article
|
82. Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development.
Gerard J.P. van Westen, Jörg K. Wegner, Peggy Geluykens, Leen Kwanten, Inge Vereycken, Anik Peeters, Adriaan P. IJzerman, Herman W.T. van Vlijmen and Andreas Bender, PLoS One 2011 e27518.

read article
|
81. Substructure-Based Virtual Screening for Adenosine A2A Receptor Ligands.
Eelke van der Horst, Rianne van der Pijl, Thea Mulder-Krieger, Andreas Bender, and Adriaan P. IJzerman, ChemMedChem 2011 (12) 2302 - 2311.

read article
|
80. Collaboration-based Function Prediction in Protein-Protein Interaction Networks.
Hossein Rahmahi, Hendrik Blockeel and Andreas Bender, Proc. IDA (Lect. Notes Comput. Sci.) 2011 (7014) 318 - 327.

read article
|
79. Interaction-Based Feature Selection for Predicting Cancer-Related Proteins in Protein-Protein Interaction Networks.
Hossein Rahmahi, Hendrik Blockeel and Andreas Bender, Proc. 5th Int. Workshop in Machine Learn. Syst. Biol. (MLSB11) 2011.

read article
|
78. From in silico target prediction to multi-target drug design: Current databases, methods and applications.
Alexios Koutsoukas, Benjamin Simms, Johannes Kirchmair, Peter J. Bond, Alan V. Whitmore, Steven Zimmer, Malcolm P. Young, Jeremy L. Jenkins, Meir Glick, Robert C. Glen and Andreas Bender, J. Proteomics 2011 (74) 2554 - 2574.

read article
|
77. Online Chemical Modeling Environment (OCHEM): Web Platform for Data Storage, Model Development and Publishing of Chemical Information.
Iurii Sushko et al., J. Comput.-Aided Mol. Des. 2011 (25) 533 - 554.

read article
|
76. P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Dataset.
Zhi Wang, Yuanying Chen, Hu Liang, Andreas Bender, Robert Glen and Aixia Yan, J. Chem. Inf. Model 2011 (51) 1447 - 1456.

read article
|
75. Efficient calculation of compound similarity based on maximum common subgraphs and its application to prediction of gene transcript levels.
Rogier J.P. van Berlo, Marco J.L. de Groot, Andreas Bender, Peter J.T. Verheijen, Marcel J.T. Reinders and Dick de Ridder, Int. J. Bioinf. Res. Appl. 2011 (in press)

read article
|
74. Diversity-oriented synthesis of macrocyclic peptidomimetics.
Albert Isidro-Llobet, Tiffanie Murillo, Paula Bello, Agostino Cilibrizzia, James T. Hodgkinson, Warren R. J. D. Galloway, Andreas Bender, Martin Welch and David R. Spring, Proc. Natl. Acad. Sci. USA 2011 (108) 6793 - 6798.

read article
|
73. Increased Diversity of Libraries from Libraries: Chemoinformatic Analysis of Bis-Diazacyclic Libraries.
Fabian Lopez-Vallejo, Adel Nefzi, Andreas Bender, John R. Owen, Ian T. Nabney, Richard A. Houghten and Jose L. Medina-Franco, Chem. Biol. Drug Des. 2011 (77) 328 - 342.

read article
|
72. Chemogenomics Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space.
Eelke van der Horst, Julio E. Peironcely, Gerard J. P. van Westen, Olaf O. van den Hoven, Warren R. J. D. Galloway, David R. Spring, Joerg K. Wegner, Herman W. T. van Vlijmen, Ad P. IJzerman, John P. Overington and Andreas Bender, Curr. Top. Med. Chem. 2011 (11) 1964 - 1977.

read article
|
71. Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets.
Gerard J. P. van Westen, Joerg K. Wegner, Adriaan P. IJzerman, Herman W. T. van Vlijmen and Andreas Bender, MedChemComm 2011 (2) 16 - 30.

read article
|
70. Bayesian Methods in Virtual Screening and Chemical Biology.
Andreas Bender, In: Bayesian Methods in Virtual Screening and Chemical Biology, Jurgen Bajorath (Ed.), Meth. Mol. Biol. 2011 (672) 175 - 196.

read article
|
More Publications
|